Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01241149 · ClinicalTrials.gov registry record · NA
Prospective Evaluation of Symptom Resolution in Acid Versus Non-acid Reflux Disease Following Anti-reflux Surgery
A NA study, sponsored by United States Naval Medical Center, Portsmouth.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01241149 is a NA study that was terminated before completion, run by United States Naval Medical Center, Portsmouth. The registered enrollment target is 12 participants.
The verdict
NCT01241149, a NA study, was terminated before completion, sponsored by United States Naval Medical Center, Portsmouth.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Gastroesophageal reflux disease (GERD) is a common ailment affecting a significant portion of the US population. With the advent and increased use of esophageal impedance monitoring, both acid and nonacid reflux disease can be better diagnosed and treated. Patients with severe symptoms or symptoms refractory to medical management may be offered anti-reflux surgery for optimal treatment. Though there are a handful of studies evaluating the efficacy of anti-reflux surgery on those patients with acid or non-acid related reflux disease, the comparison between acid and non-acid reflux disease following surgery is lacking. We propose a prospective study comparing clinical outcomes from those patients with acid versus non-acid reflux disease following anti-reflux surgery with the use of validated and disease specific quality of life surveys.
Interventions
- PROCEDURE anti-reflux surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2010-11 |
| Est. Completion | 2014-03-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01241149
The ClinicalTrials.gov registry entry for NCT01241149 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Naval Medical Center, Portsmouth, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which anti-reflux surgery is the first listed.
NCT01241149 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01241149 about?
NCT01241149 is a clinical study titled "Prospective Evaluation of Symptom Resolution in Acid Versus Non-acid Reflux Disease Following Anti-reflux Surgery". Gastroesophageal reflux disease (GERD) is a common ailment affecting a significant portion of the US population. With the advent and increased use of esophageal impedance monitoring, both acid and nonacid reflux disease can be better diagnosed and treated. Patients with severe symptoms or symptoms r...
What is the current status of trial NCT01241149?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2010-11. Estimated completion is 2014-03-26.
What interventions are being tested in trial NCT01241149?
The interventions under investigation include: anti-reflux surgery (PROCEDURE).
Who is sponsoring clinical trial NCT01241149?
This trial is sponsored by United States Naval Medical Center, Portsmouth, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.